Cargando…

Epidemiology and clinical course of COVID-19 in Shanghai, China

Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yinzhong, Zheng, Fang, Sun, Danfeng, Ling, Yun, Chen, Jun, Li, Feng, Li, Tao, Qian, Zhiping, Zhang, Yuyi, Xu, Qingnian, Liu, Li, Huang, Qin, Shan, Fei, Xu, Lie, Wu, Jun, Zhu, Zhaoqin, Song, Zhigang, Li, Shenyang, Shi, Yuxin, Zhang, Jianliang, Wu, Xueyun, Mendelsohn, Joshua B., Zhu, Tongyu, Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473125/
https://www.ncbi.nlm.nih.gov/pubmed/32573353
http://dx.doi.org/10.1080/22221751.2020.1787103
_version_ 1783579121746444288
author Shen, Yinzhong
Zheng, Fang
Sun, Danfeng
Ling, Yun
Chen, Jun
Li, Feng
Li, Tao
Qian, Zhiping
Zhang, Yuyi
Xu, Qingnian
Liu, Li
Huang, Qin
Shan, Fei
Xu, Lie
Wu, Jun
Zhu, Zhaoqin
Song, Zhigang
Li, Shenyang
Shi, Yuxin
Zhang, Jianliang
Wu, Xueyun
Mendelsohn, Joshua B.
Zhu, Tongyu
Lu, Hongzhou
author_facet Shen, Yinzhong
Zheng, Fang
Sun, Danfeng
Ling, Yun
Chen, Jun
Li, Feng
Li, Tao
Qian, Zhiping
Zhang, Yuyi
Xu, Qingnian
Liu, Li
Huang, Qin
Shan, Fei
Xu, Lie
Wu, Jun
Zhu, Zhaoqin
Song, Zhigang
Li, Shenyang
Shi, Yuxin
Zhang, Jianliang
Wu, Xueyun
Mendelsohn, Joshua B.
Zhu, Tongyu
Lu, Hongzhou
author_sort Shen, Yinzhong
collection PubMed
description Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission.
format Online
Article
Text
id pubmed-7473125
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74731252020-09-15 Epidemiology and clinical course of COVID-19 in Shanghai, China Shen, Yinzhong Zheng, Fang Sun, Danfeng Ling, Yun Chen, Jun Li, Feng Li, Tao Qian, Zhiping Zhang, Yuyi Xu, Qingnian Liu, Li Huang, Qin Shan, Fei Xu, Lie Wu, Jun Zhu, Zhaoqin Song, Zhigang Li, Shenyang Shi, Yuxin Zhang, Jianliang Wu, Xueyun Mendelsohn, Joshua B. Zhu, Tongyu Lu, Hongzhou Emerg Microbes Infect Articles Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission. Taylor & Francis 2020-07-07 /pmc/articles/PMC7473125/ /pubmed/32573353 http://dx.doi.org/10.1080/22221751.2020.1787103 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Shen, Yinzhong
Zheng, Fang
Sun, Danfeng
Ling, Yun
Chen, Jun
Li, Feng
Li, Tao
Qian, Zhiping
Zhang, Yuyi
Xu, Qingnian
Liu, Li
Huang, Qin
Shan, Fei
Xu, Lie
Wu, Jun
Zhu, Zhaoqin
Song, Zhigang
Li, Shenyang
Shi, Yuxin
Zhang, Jianliang
Wu, Xueyun
Mendelsohn, Joshua B.
Zhu, Tongyu
Lu, Hongzhou
Epidemiology and clinical course of COVID-19 in Shanghai, China
title Epidemiology and clinical course of COVID-19 in Shanghai, China
title_full Epidemiology and clinical course of COVID-19 in Shanghai, China
title_fullStr Epidemiology and clinical course of COVID-19 in Shanghai, China
title_full_unstemmed Epidemiology and clinical course of COVID-19 in Shanghai, China
title_short Epidemiology and clinical course of COVID-19 in Shanghai, China
title_sort epidemiology and clinical course of covid-19 in shanghai, china
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473125/
https://www.ncbi.nlm.nih.gov/pubmed/32573353
http://dx.doi.org/10.1080/22221751.2020.1787103
work_keys_str_mv AT shenyinzhong epidemiologyandclinicalcourseofcovid19inshanghaichina
AT zhengfang epidemiologyandclinicalcourseofcovid19inshanghaichina
AT sundanfeng epidemiologyandclinicalcourseofcovid19inshanghaichina
AT lingyun epidemiologyandclinicalcourseofcovid19inshanghaichina
AT chenjun epidemiologyandclinicalcourseofcovid19inshanghaichina
AT lifeng epidemiologyandclinicalcourseofcovid19inshanghaichina
AT litao epidemiologyandclinicalcourseofcovid19inshanghaichina
AT qianzhiping epidemiologyandclinicalcourseofcovid19inshanghaichina
AT zhangyuyi epidemiologyandclinicalcourseofcovid19inshanghaichina
AT xuqingnian epidemiologyandclinicalcourseofcovid19inshanghaichina
AT liuli epidemiologyandclinicalcourseofcovid19inshanghaichina
AT huangqin epidemiologyandclinicalcourseofcovid19inshanghaichina
AT shanfei epidemiologyandclinicalcourseofcovid19inshanghaichina
AT xulie epidemiologyandclinicalcourseofcovid19inshanghaichina
AT wujun epidemiologyandclinicalcourseofcovid19inshanghaichina
AT zhuzhaoqin epidemiologyandclinicalcourseofcovid19inshanghaichina
AT songzhigang epidemiologyandclinicalcourseofcovid19inshanghaichina
AT lishenyang epidemiologyandclinicalcourseofcovid19inshanghaichina
AT shiyuxin epidemiologyandclinicalcourseofcovid19inshanghaichina
AT zhangjianliang epidemiologyandclinicalcourseofcovid19inshanghaichina
AT wuxueyun epidemiologyandclinicalcourseofcovid19inshanghaichina
AT mendelsohnjoshuab epidemiologyandclinicalcourseofcovid19inshanghaichina
AT zhutongyu epidemiologyandclinicalcourseofcovid19inshanghaichina
AT luhongzhou epidemiologyandclinicalcourseofcovid19inshanghaichina